To determine the diagnostic yield of hyperacute ECG-gated cardiac CT compared to transthoracic echocardiogram (TTE) in detecting intra-cardiac thrombus in patients with ischemic stroke.
Approach:
Study Design: A prospective observational analysis of patients undergoing ECG-gated cardiac CT as part of hyperacute stroke imaging at a stroke center in Sydney, Australia.
Patient Selection: Included patients over 18 years with a confirmed diagnosis of ischemic stroke who underwent cardiac CT between November 2022 and December 2024.
Imaging Protocol: Utilized a 256-slice CT scanner for imaging acquisition as part of the hyperacute stroke assessment.
Key Findings:
Intra-cardiac thrombus was identified in 26% of ischemic stroke patients via cardiac CT.
Cardiac CT had a higher detection rate of intra-cardiac thrombus compared to TTE (29% vs. 2%; p < 0.001).
Patients with intra-cardiac thrombus had a higher prevalence of premorbid hypertension (94% vs. 67%; p = 0.03), heart failure (33% vs. 2%; p < 0.001), atrial fibrillation (56% vs. 24%; p = 0.01), and intracranial arterial occlusion (83% vs. 49%; p = 0.01).
Poor functional outcomes at 3 months were more common in patients with intra-cardiac thrombus (67% vs. 28%; p = 0.03).
Interpretation:
The study suggests that ECG-gated cardiac CT is more effective than TTE in detecting intra-cardiac thrombus in hyperacute ischemic stroke patients.
Limitations:
The analysis on functional outcomes is hypothesis generating and limited by a small sample size; further investigation is needed with a larger cohort and multivariable adjustment.
Conclusion:
Cardiac CT should be evaluated in hyperacute stroke imaging protocols due to its higher diagnostic yield for intra-cardiac thrombus.
by Daniel S. Green, Timmy Pham, Dennis J. Cordato, Longting Lin, Daniel Akrawi, Callan Gavaghan, Chilan Nguyen, Aaron Gaekwad, Alan McDougall, Carlos Garcia-Esperon, Anthony Kaplan, Christopher Blair, Melissa Leung, Mark W. Parsons
Plasma proteomic models of more than 40 cell types were associated with incident Alzheimer's disease, amyotrophic lateral sclerosis, cancer, and mortality across three large cohorts.
